On June 3, 2021 Merck & Co Inc. conducted a spin-off of its subsidiary Organon & Co. at a final distribution ratio of 0.10 common shares of Organon & Co. per common share of Merck & Co Inc. held. As a result of this transaction and to preserve as much as possible the nature of the reference basket, the latest was adjusted effective June 3, 2021 as follows: all shares allocated to Organon & Co. were replaced by those of Merck & Co Inc., according to an adjustment factor. Therefore, Merck & Co Inc. remains the relevant company when determining returns on the basket on each valuation date, beginning June 3, 2021.
For full details on the affected campaigns and baskets of securities, see the list of changes made to holdings (password required).
Intermediary Network Sales Support and Expertise Department